DENSE-AIR
5.6.2019 17:19:03 CEST | Business Wire | Press release
Dense Air & Dublin City Council win the 2019 Small Cell Forum Award for Social Impact – ‘Promoting Small Cells for Social/Economic/Environmental Development’. It follows successful completion of the first phase of a ground breaking 5G research and development network in Dublin’s Docklands delivered as part of the Dublin City Council (DCC) ‘Smart Docklands’ initiative.
This strategic partnership between Dense Air and DCC announced in January 2018 was intended to provide a framework for the large-scale deployment of a “pervasive” 5G connectivity solution across Dublin, and also intended to develop a blue print for future deployments globally. The initial findings have demonstrated that Neutral Host Small Cells can provide unrivalled benefits to cities and mobile operators.
Working with City council departments, national agencies, building owners and the Science Foundation Ireland CONNECT Research Centre for future networks based in TCD, Dense Air have focused on understanding how best to deploy small cells on city owned street assets build neutral-host infrastructure that can be used simultaneously, by multiple mobile network providers and private networks to simplify the small cell installation process. Having an efficient, affordable, scalable and repeatable processes, are key factors in deploying 5G small cells networks, where densification and improved indoor performance will require access to city street assets including lamp posts and traffic lights.
The judging panel stated that: “There are many interesting smart city projects involving small cells but the collaboration between Dense Air and Dublin City Council stands out for the variety of services supported, and well-quantified benefits to citizens, businesses and visitors The judges were also impressed by the neutral host model, which they believe will be very significant in lowering barriers to deployment of large networks.”
Jamie Cudden, Smart City Program Manager said:“Dublin City Council is delighted to be recognised by the Small Cell Forum for our collaboration with Dense Air. The delivery of this project was only possible through collaboration with the CONNECT research centre for future networks, local building owners and the engagement of our wider Smart Docklands partner network.
“Pervasive connectivity offers cities a clear competitive advantage and we are now ideally placed to provide a perfect live 5G test environment for companies to work with us to trial services that can help us solve different challenges. Furthermore Dublin is now providing other cities globally a template for how they can realise the future 5G opportunity.”
Paul Senior , CEO of Dense Air said “We are absolutely thrilled to have received two awards at the 2019 Small Cell Forum World Summit in London. These awards recognise Dense Air’s unique neutral host business model based on densification using small cells, and deployment and engagement we have with cities, namely Dublin City Council.”
Building on the success of this project, Dublin City Council will host the prestigious Harvard TECH Innovators Forum in partnership with Dense Air from 7-9th October 2019; Bringing together city technology leaders from across the world to share emerging best practice for 5G deployments and showcasing the Dublin Docklands 5G Pervasive Network.
Dr. David Ricketts, Innovation Fellow in the Technology in Entrepreneurship Center at Harvard (TECH) comments that, ”We are delighted to bring together cities in Dublin to share best practice experiences on how they can manage disruptive technologies in a way that will allow us to build better communities for everyone. This unique gathering will bring the top global city technology leaders together to better understand how cities can best leverage and lead on the 5G opportunity.”
https://theinnovatorsforum.org/
Dense Air is headquartered in London, UK and has offices in the target launch markets of Ireland, Belgium, Portugal, Australia & New Zealand. Dense Air provides a unique “carrier of carriers” wholesale neutral host small cell services to deliver cost-effective densification to existing mobile carriers or service providers. Dense Air is conducting extensive trials and proof-of-concepts in 2019 and will offer commercial services in 2020. Dense Air provides small cell services in Ireland based on licensed 3.4-3.8GHz radio spectrum awarded by Ireland regulator in 2017.
Dublin City Council (DCC) is leading a series of innovative partnerships with world-leading technology companies through its Smart Dublin initiative. The Smart Docklands district was set up in February 2018 to deliver and fast-track smart city projects and deployments and understand the different types of connectivity and networks that would enable future cities. This was established in partnership with CONNECT, a national research centre for connectivity and future networks. Smart Docklands was a first of its kind in Ireland, where the municipality and academia have created a dedicated Project Management Office (PMO) to play an independent role amongst multiple stakeholders, from global technology companies to local residents’ groups, from academic institutions to international property developers, innovative start-ups and SMEs to fast track emerging smart city opportunities. http://smartdocklands.ie/
View source version on businesswire.com: https://www.businesswire.com/news/home/20190605005708/en/
Contact:
Dense Air Paul Coffey Tel: 01895 467100 www.denseair.net
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
